Ontology type: schema:ScholarlyArticle
2021-11-19
AUTHORSIchiro Deguchi, Takashi Osada, Noriko Arai, Shinichi Takahashi
ABSTRACTAtrial fibrillation (AF) is a common disease encountered in daily practice; however, few patients with AF received oral anticoagulant (OAC) therapy. This study focused on differences in OAC prescriptions and influencing factors between specialists (neurological and cardiovascular) and non-specialists. A retrospective comparative analysis was conducted on 480 patients with acute cardioembolic stroke caused by non-valvular AF who were admitted to our hospital between January 1, 2015, and December 31, 2020. All patients had visited our hospital or other hospitals for their underlying diseases. Overall, 232 (specialist group SG) and 248 patients (non-specialist group NSG) were examined by specialists and non-specialists, respectively. The NSG had a significantly lower percentage of OAC prescriptions on admission than the SG (P < 0.01), even after propensity score matching. Factors influencing OAC prescription in the SG were age, hypertension, paroxysmal AF, dementia, CHADS2 score, and antiplatelet drug use, while those in the NSG were a history of cerebral infarction, paroxysmal AF, dementia, and antiplatelet drug use [SG: age, odds ratio (OR) 0.919, 95% confidence interval (CI) 0.865–0.976; hypertension, OR 0.266, 95% CI 0.099–0.713; paroxysmal AF, OR 0.189, 95% CI 0.055–0.658; dementia, OR 0.253, 95% CI 0.085–0.758; CHADS2 score, OR 2.833, 95% CI 1.682–4.942; and antiplatelet drug use, OR 0.072, 95% CI 0.025–0.206; NSG: cerebral infarction, OR 5.940, 95% CI 1.581–22.309; paroxysmal AF, OR 0.077, 95% CI 0.010–0.623; dementia, OR 0.077, 95% CI 0.014–0.438; and antiplatelet drug use, OR 0.024, 95% CI 0.004–0.152]. In conclusion, the OAC prescription rate was higher in patients with non-valvular AF whose family physicians were specialists at the time of cerebral infarction onset. In addition, in the SG, advanced age and hypertension were associated with not prescribing OAC, whereas a higher CHADS2 score was associated with the prescription of OACs. In the NSG, a history of cerebral infarction was associated with the prescription of OACs. Further, paroxysmal AF, antiplatelet drug use, and dementia were associated with non-OAC therapy in both the groups. More... »
PAGES867-874
http://scigraph.springernature.com/pub.10.1007/s00380-021-01984-y
DOIhttp://dx.doi.org/10.1007/s00380-021-01984-y
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1142692617
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/34797401
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Administration, Oral",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Anticoagulants",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Atrial Fibrillation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cerebral Infarction",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Dementia",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Embolic Stroke",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hypertension",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Platelet Aggregation Inhibitors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prescriptions",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Risk Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Stroke",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, 350-1298, Hidaka, Saitama, Japan",
"id": "http://www.grid.ac/institutes/grid.412377.4",
"name": [
"Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, 350-1298, Hidaka, Saitama, Japan"
],
"type": "Organization"
},
"familyName": "Deguchi",
"givenName": "Ichiro",
"id": "sg:person.0744067402.10",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744067402.10"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, 350-1298, Hidaka, Saitama, Japan",
"id": "http://www.grid.ac/institutes/grid.412377.4",
"name": [
"Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, 350-1298, Hidaka, Saitama, Japan"
],
"type": "Organization"
},
"familyName": "Osada",
"givenName": "Takashi",
"id": "sg:person.01175454414.57",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175454414.57"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, 350-1298, Hidaka, Saitama, Japan",
"id": "http://www.grid.ac/institutes/grid.412377.4",
"name": [
"Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, 350-1298, Hidaka, Saitama, Japan"
],
"type": "Organization"
},
"familyName": "Arai",
"givenName": "Noriko",
"id": "sg:person.07427466240.00",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07427466240.00"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, 350-1298, Hidaka, Saitama, Japan",
"id": "http://www.grid.ac/institutes/grid.412377.4",
"name": [
"Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, 350-1298, Hidaka, Saitama, Japan"
],
"type": "Organization"
},
"familyName": "Takahashi",
"givenName": "Shinichi",
"id": "sg:person.014015104711.10",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014015104711.10"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s40266-017-0477-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1090653366",
"https://doi.org/10.1007/s40266-017-0477-3"
],
"type": "CreativeWork"
}
],
"datePublished": "2021-11-19",
"datePublishedReg": "2021-11-19",
"description": "Atrial fibrillation (AF) is a common disease encountered in daily practice; however, few patients with AF received oral anticoagulant (OAC) therapy. This study focused on differences in OAC prescriptions and influencing factors between specialists (neurological and cardiovascular) and non-specialists. A retrospective comparative analysis was conducted on 480 patients with acute cardioembolic stroke caused by non-valvular AF who were admitted to our hospital between January 1, 2015, and December 31, 2020. All patients had visited our hospital or other hospitals for their underlying diseases. Overall, 232 (specialist group SG) and 248 patients (non-specialist group NSG) were examined by specialists and non-specialists, respectively. The NSG had a significantly lower percentage of OAC prescriptions on admission than the SG (P\u2009<\u20090.01), even after propensity score matching. Factors influencing OAC prescription in the SG were age, hypertension, paroxysmal AF, dementia, CHADS2 score, and antiplatelet drug use, while those in the NSG were a history of cerebral infarction, paroxysmal AF, dementia, and antiplatelet drug use [SG: age, odds ratio (OR) 0.919, 95% confidence interval (CI) 0.865\u20130.976; hypertension, OR 0.266, 95% CI 0.099\u20130.713; paroxysmal AF, OR 0.189, 95% CI 0.055\u20130.658; dementia, OR 0.253, 95% CI 0.085\u20130.758; CHADS2 score, OR 2.833, 95% CI 1.682\u20134.942; and antiplatelet drug use, OR 0.072, 95% CI 0.025\u20130.206; NSG: cerebral infarction, OR 5.940, 95% CI 1.581\u201322.309; paroxysmal AF, OR 0.077, 95% CI 0.010\u20130.623; dementia, OR 0.077, 95% CI 0.014\u20130.438; and antiplatelet drug use, OR 0.024, 95% CI 0.004\u20130.152]. In conclusion, the OAC prescription rate was higher in patients with non-valvular AF whose family physicians were specialists at the time of cerebral infarction onset. In addition, in the SG, advanced age and hypertension were associated with not prescribing OAC, whereas a higher CHADS2 score was associated with the prescription of OACs. In the NSG, a history of cerebral infarction was associated with the prescription of OACs. Further, paroxysmal AF, antiplatelet drug use, and dementia were associated with non-OAC therapy in both the groups.",
"genre": "article",
"id": "sg:pub.10.1007/s00380-021-01984-y",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1095887",
"issn": [
"0910-8327",
"1615-2573"
],
"name": "Heart and Vessels",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "5",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "37"
}
],
"keywords": [
"non-valvular atrial fibrillation",
"antiplatelet drug use",
"paroxysmal atrial fibrillation",
"prescription of OACs",
"atrial fibrillation",
"OAC prescription",
"drug use",
"CHADS2 score",
"cardioembolic stroke",
"cerebral infarction",
"acute cardioembolic stroke",
"OAC prescription rates",
"cerebral infarction onset",
"high CHADS2 score",
"oral anticoagulant prescriptions",
"oral anticoagulant therapy",
"retrospective comparative analysis",
"anticoagulant prescription",
"anticoagulant therapy",
"underlying disease",
"prescription rates",
"advanced age",
"infarction onset",
"family physicians",
"patients",
"common disease",
"hospital",
"dementia",
"daily practice",
"prescription",
"hypertension",
"infarction",
"fibrillation",
"therapy",
"stroke",
"disease",
"lower percentage",
"age",
"NSG",
"scores",
"specialists",
"admission",
"OAC",
"physicians",
"SG",
"factors",
"differences",
"history",
"onset",
"conclusion",
"use",
"group",
"percentage",
"study",
"rate",
"propensity",
"practice",
"addition",
"time",
"analysis",
"comparative analysis"
],
"name": "Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation",
"pagination": "867-874",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1142692617"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00380-021-01984-y"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"34797401"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00380-021-01984-y",
"https://app.dimensions.ai/details/publication/pub.1142692617"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-10T10:31",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_904.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s00380-021-01984-y"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-01984-y'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-01984-y'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-01984-y'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00380-021-01984-y'
This table displays all metadata directly associated to this object as RDF triples.
200 TRIPLES
22 PREDICATES
101 URIs
92 LITERALS
20 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s00380-021-01984-y | schema:about | N0f241ad07da34c22aacb9b92859e6351 |
2 | ″ | ″ | N116cae60d44c4c1aae87cf4413eabd9d |
3 | ″ | ″ | N3be69d9b477b4acbb33c4f1edeb3c8d4 |
4 | ″ | ″ | N57e5cfb7d35644ef8d94a43ab5fd3ff6 |
5 | ″ | ″ | N65bbaf72a4db44f099127332f8a296d8 |
6 | ″ | ″ | N80bb316b38024099a76f4e808951357c |
7 | ″ | ″ | N9011103b04da4fda893b332077e7baa0 |
8 | ″ | ″ | N925955be285444069c4aa74ec5923708 |
9 | ″ | ″ | Na857e675f2734d6d9697bdddf5178c37 |
10 | ″ | ″ | Nb45f78b775d5425199820c8bee0c89f4 |
11 | ″ | ″ | Nc6aa031bc76241318823e2990cb692b3 |
12 | ″ | ″ | Ne66741215316471bb595f761fc310239 |
13 | ″ | ″ | Nfaafefd0ef0d44398bff48a81da886b2 |
14 | ″ | ″ | anzsrc-for:11 |
15 | ″ | ″ | anzsrc-for:1102 |
16 | ″ | schema:author | N942aa5a0867748f0ae82a23f7d60b994 |
17 | ″ | schema:citation | sg:pub.10.1007/s40266-017-0477-3 |
18 | ″ | schema:datePublished | 2021-11-19 |
19 | ″ | schema:datePublishedReg | 2021-11-19 |
20 | ″ | schema:description | Atrial fibrillation (AF) is a common disease encountered in daily practice; however, few patients with AF received oral anticoagulant (OAC) therapy. This study focused on differences in OAC prescriptions and influencing factors between specialists (neurological and cardiovascular) and non-specialists. A retrospective comparative analysis was conducted on 480 patients with acute cardioembolic stroke caused by non-valvular AF who were admitted to our hospital between January 1, 2015, and December 31, 2020. All patients had visited our hospital or other hospitals for their underlying diseases. Overall, 232 (specialist group SG) and 248 patients (non-specialist group NSG) were examined by specialists and non-specialists, respectively. The NSG had a significantly lower percentage of OAC prescriptions on admission than the SG (P < 0.01), even after propensity score matching. Factors influencing OAC prescription in the SG were age, hypertension, paroxysmal AF, dementia, CHADS2 score, and antiplatelet drug use, while those in the NSG were a history of cerebral infarction, paroxysmal AF, dementia, and antiplatelet drug use [SG: age, odds ratio (OR) 0.919, 95% confidence interval (CI) 0.865–0.976; hypertension, OR 0.266, 95% CI 0.099–0.713; paroxysmal AF, OR 0.189, 95% CI 0.055–0.658; dementia, OR 0.253, 95% CI 0.085–0.758; CHADS2 score, OR 2.833, 95% CI 1.682–4.942; and antiplatelet drug use, OR 0.072, 95% CI 0.025–0.206; NSG: cerebral infarction, OR 5.940, 95% CI 1.581–22.309; paroxysmal AF, OR 0.077, 95% CI 0.010–0.623; dementia, OR 0.077, 95% CI 0.014–0.438; and antiplatelet drug use, OR 0.024, 95% CI 0.004–0.152]. In conclusion, the OAC prescription rate was higher in patients with non-valvular AF whose family physicians were specialists at the time of cerebral infarction onset. In addition, in the SG, advanced age and hypertension were associated with not prescribing OAC, whereas a higher CHADS2 score was associated with the prescription of OACs. In the NSG, a history of cerebral infarction was associated with the prescription of OACs. Further, paroxysmal AF, antiplatelet drug use, and dementia were associated with non-OAC therapy in both the groups. |
21 | ″ | schema:genre | article |
22 | ″ | schema:inLanguage | en |
23 | ″ | schema:isAccessibleForFree | false |
24 | ″ | schema:isPartOf | Ncfeae4a905544ae7b4f6366c6510dd87 |
25 | ″ | ″ | Nd200c64b21ef4234a1a29482842013bc |
26 | ″ | ″ | sg:journal.1095887 |
27 | ″ | schema:keywords | CHADS2 score |
28 | ″ | ″ | NSG |
29 | ″ | ″ | OAC |
30 | ″ | ″ | OAC prescription |
31 | ″ | ″ | OAC prescription rates |
32 | ″ | ″ | SG |
33 | ″ | ″ | acute cardioembolic stroke |
34 | ″ | ″ | addition |
35 | ″ | ″ | admission |
36 | ″ | ″ | advanced age |
37 | ″ | ″ | age |
38 | ″ | ″ | analysis |
39 | ″ | ″ | anticoagulant prescription |
40 | ″ | ″ | anticoagulant therapy |
41 | ″ | ″ | antiplatelet drug use |
42 | ″ | ″ | atrial fibrillation |
43 | ″ | ″ | cardioembolic stroke |
44 | ″ | ″ | cerebral infarction |
45 | ″ | ″ | cerebral infarction onset |
46 | ″ | ″ | common disease |
47 | ″ | ″ | comparative analysis |
48 | ″ | ″ | conclusion |
49 | ″ | ″ | daily practice |
50 | ″ | ″ | dementia |
51 | ″ | ″ | differences |
52 | ″ | ″ | disease |
53 | ″ | ″ | drug use |
54 | ″ | ″ | factors |
55 | ″ | ″ | family physicians |
56 | ″ | ″ | fibrillation |
57 | ″ | ″ | group |
58 | ″ | ″ | high CHADS2 score |
59 | ″ | ″ | history |
60 | ″ | ″ | hospital |
61 | ″ | ″ | hypertension |
62 | ″ | ″ | infarction |
63 | ″ | ″ | infarction onset |
64 | ″ | ″ | lower percentage |
65 | ″ | ″ | non-valvular atrial fibrillation |
66 | ″ | ″ | onset |
67 | ″ | ″ | oral anticoagulant prescriptions |
68 | ″ | ″ | oral anticoagulant therapy |
69 | ″ | ″ | paroxysmal atrial fibrillation |
70 | ″ | ″ | patients |
71 | ″ | ″ | percentage |
72 | ″ | ″ | physicians |
73 | ″ | ″ | practice |
74 | ″ | ″ | prescription |
75 | ″ | ″ | prescription of OACs |
76 | ″ | ″ | prescription rates |
77 | ″ | ″ | propensity |
78 | ″ | ″ | rate |
79 | ″ | ″ | retrospective comparative analysis |
80 | ″ | ″ | scores |
81 | ″ | ″ | specialists |
82 | ″ | ″ | stroke |
83 | ″ | ″ | study |
84 | ″ | ″ | therapy |
85 | ″ | ″ | time |
86 | ″ | ″ | underlying disease |
87 | ″ | ″ | use |
88 | ″ | schema:name | Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation |
89 | ″ | schema:pagination | 867-874 |
90 | ″ | schema:productId | N02ddaa46076e4b76a2cc1649988ad537 |
91 | ″ | ″ | N04038a2234ca424db128c04612e87be2 |
92 | ″ | ″ | N83690a9a4eb14e0e9d008bb0485bdb5e |
93 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1142692617 |
94 | ″ | ″ | https://doi.org/10.1007/s00380-021-01984-y |
95 | ″ | schema:sdDatePublished | 2022-05-10T10:31 |
96 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
97 | ″ | schema:sdPublisher | N4aa1e40d1b9b4b4f97cc85c9796d20bf |
98 | ″ | schema:url | https://doi.org/10.1007/s00380-021-01984-y |
99 | ″ | sgo:license | sg:explorer/license/ |
100 | ″ | sgo:sdDataset | articles |
101 | ″ | rdf:type | schema:ScholarlyArticle |
102 | N02ddaa46076e4b76a2cc1649988ad537 | schema:name | dimensions_id |
103 | ″ | schema:value | pub.1142692617 |
104 | ″ | rdf:type | schema:PropertyValue |
105 | N04038a2234ca424db128c04612e87be2 | schema:name | doi |
106 | ″ | schema:value | 10.1007/s00380-021-01984-y |
107 | ″ | rdf:type | schema:PropertyValue |
108 | N0f241ad07da34c22aacb9b92859e6351 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
109 | ″ | schema:name | Humans |
110 | ″ | rdf:type | schema:DefinedTerm |
111 | N116cae60d44c4c1aae87cf4413eabd9d | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
112 | ″ | schema:name | Hypertension |
113 | ″ | rdf:type | schema:DefinedTerm |
114 | N3be69d9b477b4acbb33c4f1edeb3c8d4 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
115 | ″ | schema:name | Anticoagulants |
116 | ″ | rdf:type | schema:DefinedTerm |
117 | N4aa1e40d1b9b4b4f97cc85c9796d20bf | schema:name | Springer Nature - SN SciGraph project |
118 | ″ | rdf:type | schema:Organization |
119 | N57e5cfb7d35644ef8d94a43ab5fd3ff6 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
120 | ″ | schema:name | Embolic Stroke |
121 | ″ | rdf:type | schema:DefinedTerm |
122 | N615ca6a19b1a4046b1be01b11d0257cf | rdf:first | sg:person.01175454414.57 |
123 | ″ | rdf:rest | Ndee04668d5fa4839a4c5956e59c3b823 |
124 | N65bbaf72a4db44f099127332f8a296d8 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
125 | ″ | schema:name | Retrospective Studies |
126 | ″ | rdf:type | schema:DefinedTerm |
127 | N80bb316b38024099a76f4e808951357c | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
128 | ″ | schema:name | Atrial Fibrillation |
129 | ″ | rdf:type | schema:DefinedTerm |
130 | N83690a9a4eb14e0e9d008bb0485bdb5e | schema:name | pubmed_id |
131 | ″ | schema:value | 34797401 |
132 | ″ | rdf:type | schema:PropertyValue |
133 | N9011103b04da4fda893b332077e7baa0 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
134 | ″ | schema:name | Prescriptions |
135 | ″ | rdf:type | schema:DefinedTerm |
136 | N925955be285444069c4aa74ec5923708 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
137 | ″ | schema:name | Administration, Oral |
138 | ″ | rdf:type | schema:DefinedTerm |
139 | N942aa5a0867748f0ae82a23f7d60b994 | rdf:first | sg:person.0744067402.10 |
140 | ″ | rdf:rest | N615ca6a19b1a4046b1be01b11d0257cf |
141 | Na76c387fb76b408ca06d3acbc0e3b91e | rdf:first | sg:person.014015104711.10 |
142 | ″ | rdf:rest | rdf:nil |
143 | Na857e675f2734d6d9697bdddf5178c37 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
144 | ″ | schema:name | Dementia |
145 | ″ | rdf:type | schema:DefinedTerm |
146 | Nb45f78b775d5425199820c8bee0c89f4 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
147 | ″ | schema:name | Stroke |
148 | ″ | rdf:type | schema:DefinedTerm |
149 | Nc6aa031bc76241318823e2990cb692b3 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
150 | ″ | schema:name | Cerebral Infarction |
151 | ″ | rdf:type | schema:DefinedTerm |
152 | Ncfeae4a905544ae7b4f6366c6510dd87 | schema:issueNumber | 5 |
153 | ″ | rdf:type | schema:PublicationIssue |
154 | Nd200c64b21ef4234a1a29482842013bc | schema:volumeNumber | 37 |
155 | ″ | rdf:type | schema:PublicationVolume |
156 | Ndee04668d5fa4839a4c5956e59c3b823 | rdf:first | sg:person.07427466240.00 |
157 | ″ | rdf:rest | Na76c387fb76b408ca06d3acbc0e3b91e |
158 | Ne66741215316471bb595f761fc310239 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
159 | ″ | schema:name | Risk Factors |
160 | ″ | rdf:type | schema:DefinedTerm |
161 | Nfaafefd0ef0d44398bff48a81da886b2 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
162 | ″ | schema:name | Platelet Aggregation Inhibitors |
163 | ″ | rdf:type | schema:DefinedTerm |
164 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
165 | ″ | schema:name | Medical and Health Sciences |
166 | ″ | rdf:type | schema:DefinedTerm |
167 | anzsrc-for:1102 | schema:inDefinedTermSet | anzsrc-for: |
168 | ″ | schema:name | Cardiorespiratory Medicine and Haematology |
169 | ″ | rdf:type | schema:DefinedTerm |
170 | sg:journal.1095887 | schema:issn | 0910-8327 |
171 | ″ | ″ | 1615-2573 |
172 | ″ | schema:name | Heart and Vessels |
173 | ″ | schema:publisher | Springer Nature |
174 | ″ | rdf:type | schema:Periodical |
175 | sg:person.01175454414.57 | schema:affiliation | grid-institutes:grid.412377.4 |
176 | ″ | schema:familyName | Osada |
177 | ″ | schema:givenName | Takashi |
178 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175454414.57 |
179 | ″ | rdf:type | schema:Person |
180 | sg:person.014015104711.10 | schema:affiliation | grid-institutes:grid.412377.4 |
181 | ″ | schema:familyName | Takahashi |
182 | ″ | schema:givenName | Shinichi |
183 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014015104711.10 |
184 | ″ | rdf:type | schema:Person |
185 | sg:person.07427466240.00 | schema:affiliation | grid-institutes:grid.412377.4 |
186 | ″ | schema:familyName | Arai |
187 | ″ | schema:givenName | Noriko |
188 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07427466240.00 |
189 | ″ | rdf:type | schema:Person |
190 | sg:person.0744067402.10 | schema:affiliation | grid-institutes:grid.412377.4 |
191 | ″ | schema:familyName | Deguchi |
192 | ″ | schema:givenName | Ichiro |
193 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744067402.10 |
194 | ″ | rdf:type | schema:Person |
195 | sg:pub.10.1007/s40266-017-0477-3 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1090653366 |
196 | ″ | ″ | https://doi.org/10.1007/s40266-017-0477-3 |
197 | ″ | rdf:type | schema:CreativeWork |
198 | grid-institutes:grid.412377.4 | schema:alternateName | Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, 350-1298, Hidaka, Saitama, Japan |
199 | ″ | schema:name | Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, 350-1298, Hidaka, Saitama, Japan |
200 | ″ | rdf:type | schema:Organization |